Conferences \ Circulating Biomarkers World Congress 2015 \ Agenda \ Xandra Breakefield |
Register | Login |
Extracellular RNA in Biofluids as Biomarkers of DiseaseMonday, 23 March 2015 at 11:30 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com Most cells in the body release extracellular RNA (exRNA) within vesicles or in association with ribonucleoprotein/lipoprotein particles. This overview talk will consider the types of RNA released, the biofluids analyzed, and modes of evaluation of the quantity and sequence of exRNAs as a index of different disease states. Examples will be provided for analysis of exRNA from serum/plasma, urine and cerebral spinal fluid of cancer patients with a focus on discovery of novel non-coding RNAs and quantitation of rare, mutant RNAs. Extracellular RNA in Biofluids as Biomarkers of DiseaseMonday, 23 March 2015 at 11:30 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com Most cells in the body release extracellular RNA (exRNA) within vesicles or in association with ribonucleoprotein/lipoprotein particles. This overview talk will consider the types of RNA released, the biofluids analyzed, and modes of evaluation of the quantity and sequence of exRNAs as a index of different disease states. Examples will be provided for analysis of exRNA from serum/plasma, urine and cerebral spinal fluid of cancer patients with a focus on discovery of novel non-coding RNAs and quantitation of rare, mutant RNAs. Extracellular RNA in Biofluids as Biomarkers of DiseaseMonday, 23 March 2015 at 11:30 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com Most cells in the body release extracellular RNA (exRNA) within vesicles or in association with ribonucleoprotein/lipoprotein particles. This overview talk will consider the types of RNA released, the biofluids analyzed, and modes of evaluation of the quantity and sequence of exRNAs as a index of different disease states. Examples will be provided for analysis of exRNA from serum/plasma, urine and cerebral spinal fluid of cancer patients with a focus on discovery of novel non-coding RNAs and quantitation of rare, mutant RNAs. |